Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neel M Butala

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT StudyKamil F Faridi, Hector Tamez, Neel M Butala, et al.
JACC. Cardiovascular Interventions|October 8, 2021
Applicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice: Findings From EXTEND-CoreValveNeel M Butala, Eric Secemsky, Dhruv S Kazi, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular LithotripsyNeel M Butala, Stephen W Waldo, Eric A Secemsky, et al.
American Heart Journal|October 29, 2022
Days at home after transcatheter or surgical aortic valve replacement in high-risk patientsMabel Chung, Neel M Butala, Kamil F Faridi, et al.
Circulation|July 21, 2020
Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT StudyKamil F Faridi, Hector Tamez, Jordan B Strom, et al.
Circulation. Cardiovascular Quality and Outcomes|March 29, 2025
Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve ReplacementChristina Lalani, Frank Medina, Andrew S Oseran, et al.
Journal of the American Heart Association|July 14, 2023
Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT StudyKamil F Faridi, Jordan B Strom, Harun Kundi, et al.
Circulation|May 22, 2020
Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND StudyJordan B Strom, Kamil F Faridi, Neel M Butala, et al.
Circulation. Cardiovascular Interventions|November 8, 2019
Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND StudyJordan B Strom, Yuansong Zhao, Kamil F Faridi, et al.
The American Journal of Cardiology|May 12, 2025
Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights From the CathPCI RegistryChristina Lalani, Ravi K Sharma, Jonathan Sevilla-Cazes, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT StudyKamil F Faridi, Hector Tamez, Neel M Butala, et al.
JACC. Cardiovascular Interventions|October 8, 2021
Applicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice: Findings From EXTEND-CoreValveNeel M Butala, Eric Secemsky, Dhruv S Kazi, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular LithotripsyNeel M Butala, Stephen W Waldo, Eric A Secemsky, et al.
American Heart Journal|October 29, 2022
Days at home after transcatheter or surgical aortic valve replacement in high-risk patientsMabel Chung, Neel M Butala, Kamil F Faridi, et al.
Circulation|July 21, 2020
Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT StudyKamil F Faridi, Hector Tamez, Jordan B Strom, et al.
Circulation. Cardiovascular Quality and Outcomes|March 29, 2025
Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve ReplacementChristina Lalani, Frank Medina, Andrew S Oseran, et al.
Journal of the American Heart Association|July 14, 2023
Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT StudyKamil F Faridi, Jordan B Strom, Harun Kundi, et al.
Circulation|May 22, 2020
Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND StudyJordan B Strom, Kamil F Faridi, Neel M Butala, et al.
Circulation. Cardiovascular Interventions|November 8, 2019
Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND StudyJordan B Strom, Yuansong Zhao, Kamil F Faridi, et al.
The American Journal of Cardiology|May 12, 2025
Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights From the CathPCI RegistryChristina Lalani, Ravi K Sharma, Jonathan Sevilla-Cazes, et al.
Pageof 7